Navigation Links
Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
Date:11/6/2008

WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company has initiated a Phase 2b clinical trial to evaluate the use of RG2417, an oral formulation of uridine, in patients with bipolar depression. This Phase 2b study is a multi-center, randomized, double-blind, placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or placebo twice daily for eight weeks. This study is designed to assess the safety and efficacy of RG2417 as measured by the Montgomery-Asberg Depression Rating Scale (MADRS) and the Clinical Global Impression of Change in Bipolar Disorder Scale (CGI-BP-C). The study will be conducted at approximately 20 clinical sites within the United States. The Principal Investigator of this study is Gary S. Sachs, M.D., founder and director of the Bipolar Clinic and Research Program at the Massachusetts General Hospital and an Associate Professor of Psychiatry at the Harvard Medical School.

"Episodes of depression are the most frequent and long-lived symptom of bipolar disorder and account for the majority of the disease impairment. Current therapies used to treat bipolar depression are often ineffective and may have significant side effects, resulting in bipolar depression as an area of high unmet medical need," said Walter C. Herlihy, President and Chief Executive Officer of Repligen. "We look forward to confirming our prior results with RG2417 in bipolar depression in this larger proof-of-concept clinical trial."

The trial is designed to confirm and extend the results obtained in a positive Phase 2a clinical trial of RG2417 in which 83 patients with bipolar disorder received either RG2417 or place
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
2. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
3. Repligen Elects Earl Henry, M.D. to the Board of Directors
4. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
5. Repligen Announces Share Repurchase Program
6. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
7. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
8. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
9. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
10. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
11. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... York (PRWEB) April 17, 2015 ... allege this class of prescription medications increases the ... attack, stroke or other life-threatening cardiovascular event continue ... U.S. District Court, Northern District of Illinois. According ... U.S. Judicial Panel on Multidistrict Litigation (JPML) on ...
(Date:4/17/2015)... San Francisco, CA (PRWEB) April 17, 2015 The ... Open House event and Free Application Day on April 29. The ... the ACTCM Pioneer Square, located at 555 DeHaro St. in San ... , 11 a.m. – Check in at the DeHaro campus (room ... a.m. – Tour of campus, Noon – Light lunch with current ...
(Date:4/17/2015)... April 17, 2015 With Dr. Taj ... has spent the last four years providing residents ... procedures ranging from general cleanings to dental implants and ... opening at their new office in North Charlotte. , ... as their Concord office, including denture fittings, cosmetic procedures, ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 ... to polish and perfect facial skin with its ... seeds and blend of energizing botanicals. This cushiony ... cells that cause breakouts and inhibit penetration of ... , Ecuadorian Ivory Palm Seeds, This uncommon exfoliating ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Verndale, a ... it has once again been chosen as a Boston ... growing private company in the region. The BBJ’s Pacesetters ... growth from 2011 through 2014. This is the eighth ... ten years that Verndale has been honored with this ...
Breaking Medicine News(10 mins):Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:American College of Traditional Chinese Medicine Hosts Open House 2Health News:Mario Badescu Skin Care Launches Botanical Exfoliating Scrub 2Health News:Verndale Honored as 2015 Boston Business Journal Pacesetter, Named 46th Fastest Growing Private Company 2
... Va. Research reported in the October issue of ... a molecular imaging technique may prove useful in early ... "One of the most promising aspects of molecular ... long before changes in the tumor size and shape ...
... review article published in the October issue of ... Clinic physicians differentiate the ethical and legal permissibility ... comfort measures, specifically palliative sedation, from that of ... that palliative sedation has an important place on ...
... published study in the October 2010 issue of The ... conducted at New York University,s College of Dentistry, confirms ... for controlling xerostomia, or dry mouth. The double masked, ... unique mucoadhesive patch, affixed to the hard palate inside ...
... It Real," an evidence-based sex education curriculum developed by researchers ... (UTHealth), will be implemented in select public schools across the ... tackle the U.S. teenage pregnancy rate. The U.S. ... of its $155-million total package to a team led by ...
... sciences for the developing world, will hold its 21st General ... 350 scientists from 35 countries are expected to attend. Dr. ... delegates at the opening ceremony. The opening ceremony will ... Ernesto Illy Trieste Science Prize and the official presentation of ...
... is a major cause of vision problems in children and ... 70 in developed countries. In amblyopia the person,s stronger eye ... as a result. When the condition is detected and treated ... 20/30 vision or better, the Amblyopia Treatment Study reports. But ...
Cached Medicine News:Health News:Evaluation of targeted therapy in ovarian cancer 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 3Health News:UTHealth researchers awarded $15 million for teen pregnancy prevention 2Health News:TWAS to meet in India 2Health News:Is photoscreening the best way to catch 'lazy eye'? 2
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) has announced ... Strategic Business Report" report to their offering. ... Testing in US$ Million by the following Segments: Toxicology ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Mammography Equipment - Global Strategic Business Report" report ... worldwide markets for Mammography Equipment in US$ Thousands by ... Mammography Equipment. The report provides separate comprehensive analytics for ... Japan , Europe , ...
(Date:4/17/2015)... , April 17, 2015 Today, the ... 13 employees from 12 biopharmaceutical companies as "We ... in policy advocacy and community service. ... Champion Awards were created by the biopharmaceutical industry ... in their careers, but have also shown an ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3
... leading provider of medical supplies for care at home, is ... story contest winners. Congratulations to the grand prize winners: LaNedra ... G. of Olympia, WA, and the 5 runners-up, Vivian B. ... of Ypsilanti, MI, Tiffany H. of Monroe, WA and Jorge ...
... of Kensey Nash Corporation (Nasdaq: KNSY ) announced ... $0.25 per share of the Company,s common stock, ... dividend will be paid on February 29, 2012.  This declaration ... board of directors expects to declare a total annual dividend ...
Cached Medicine Technology:Shield HealthCare Announces Caregiver Story Contest Winners 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 3Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 12 mm....
Medicine Products: